Trial Profile
A randomised controlled trial evaluating the effects of neostigmine vs. sugammadex-based reversal of rocuronium on postoperative morbidity and mortality in high risk elderly patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2021
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine
- Indications Neuromuscular blockade; Postoperative complications
- Focus Therapeutic Use
- 11 Jun 2021 Results investigating prospectively the incidence of postoperative pulmonary complications after reversal with either sugammadex (SUG) or neostigmine (NEO) in high-risk older patients published in the British Journal of Anaesthesia
- 08 Jun 2016 Status changed from not yet recruiting to recruiting.
- 28 Mar 2014 New trial record